Cambridge Investment Research Advisors
CBAY

Cambridge Investment Research Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,533
Closed -$249K – 3421
2023
Q4 		$249K Buy
+10,533
New +$188K ﹤0.01% 2745
2019
Q3 		– Sell
-11,200
Closed -$80K – 2426
2019
Q2 		$80K Buy
+11,200
New +$127K ﹤0.01% 2118

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cambridge Investment Research Advisors's CBAY Position: Q1 2024 in Review

Cambridge Investment Research Advisors sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 10,533 shares — an estimated $249K sold.

Cambridge Investment Research Advisors first reported a position in CBAY in Q2 2019 and held it in 2 quarters. The position peaked at $249K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Cambridge Investment Research Advisors reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,533 Cymabay Therapeutics shares in Q1 2024, an estimated $249K.
  • Cambridge Investment Research Advisors first reported a position in Cymabay Therapeutics in Q2 2019 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Cymabay Therapeutics position peaked at $249K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.